methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate

C53H86O17 — CID 70696902

IUPACmethyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate
SMILESCOC(=O)[C@H](O)C/C=C\C/C=C/C[C@@H]1O[C@@]23C[C@@H]1OC(=O)C[C@H]1CCC[C@@H](C[C@@H](O)C[C@H](O)C[C@H]4O[C@@]5(CC[C@H](OC)[C@H](O5)[C@@H](O)[C@@H](O)[C@@H](C)CC[C@@H]5C[C@H](OC)C[C@](CC[C@@H]2C)(O5)O3)CC[C@@H]4C)O1
InChIInChI=1S/C53H86O17/c1-32-19-22-51-24-21-43(62-5)49(69-51)48(59)47(58)33(2)17-18-39-28-40(61-4)30-52(66-39)23-20-34(3)53(70-52)31-45(42(68-53)16-11-9-7-8-10-15-41(56)50(60)63-6)65-46(57)29-38-14-12-13-37(64-38)26-35(54)25-36(55)27-44(32)67-51/h8-11,32-45,47-49,54-56,58-59H,7,12-31H2,1-6H3/b10-8-,11-9+/t32-,33-,34-,35-,36-,37-,38+,39+,40-,41+,42-,43-,44+,45-,47-,48-,49-,51-,52+,53+/m0/s1
InChIKeyNDHIPICYVWOHPY-MFFODREMSA-N
MW995.25 g/mol
LogP5.61
Rot. Bonds9

About methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate

methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate (PubChem CID 70696902) has the molecular formula C53H86O17 and a molecular weight of 995.25 g/mol. Its IUPAC name is methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate.

Molecular Properties

Compound Namemethyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate
PubChem CID70696902
Molecular FormulaC53H86O17
Molecular Weight995.25 g/mol
Exact Mass994.59
IUPAC Namemethyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate
SMILESCOC(=O)[C@H](O)C/C=C\C/C=C/C[C@@H]1O[C@@]23C[C@@H]1OC(=O)C[C@H]1CCC[C@@H](C[C@@H](O)C[C@H](O)C[C@H]4O[C@@]5(CC[C@H](OC)[C@H](O5)[C@@H](O)[C@@H](O)[C@@H](C)CC[C@@H]5C[C@H](OC)C[C@](CC[C@@H]2C)(O5)O3)CC[C@@H]4C)O1
InChIInChI=1S/C53H86O17/c1-32-19-22-51-24-21-43(62-5)49(69-51)48(59)47(58)33(2)17-18-39-28-40(61-4)30-52(66-39)23-20-34(3)53(70-52)31-45(42(68-53)16-11-9-7-8-10-15-41(56)50(60)63-6)65-46(57)29-38-14-12-13-37(64-38)26-35(54)25-36(55)27-44(32)67-51/h8-11,32-45,47-49,54-56,58-59H,7,12-31H2,1-6H3/b10-8-,11-9+/t32-,33-,34-,35-,36-,37-,38+,39+,40-,41+,42-,43-,44+,45-,47-,48-,49-,51-,52+,53+/m0/s1
InChIKeyNDHIPICYVWOHPY-MFFODREMSA-N
XLogP5.61
TPSA227.59 Ų
H-Bond Donors5
H-Bond Acceptors17
Rotatable Bonds9
Heavy Atoms70
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500995.25
LogP ≤ 55.61
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1017

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate?
The IUPAC name of methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate (CID 70696902) is methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate.
What is the SMILES notation for methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate?
The canonical SMILES for methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate is COC(=O)[C@H](O)C/C=C\C/C=C/C[C@@H]1O[C@@]23C[C@@H]1OC(=O)C[C@H]1CCC[C@@H](C[C@@H](O)C[C@H](O)C[C@H]4O[C@@]5(CC[C@H](OC)[C@H](O5)[C@@H](O)[C@@H](O)[C@@H](C)CC[C@@H]5C[C@H](OC)C[C@](CC[C@@H]2C)(O5)O3)CC[C@@H]4C)O1.
What is the InChIKey of methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate?
The InChIKey is NDHIPICYVWOHPY-MFFODREMSA-N. The full InChI is InChI=1S/C53H86O17/c1-32-19-22-51-24-21-43(62-5)49(69-51)48(59)47(58)33(2)17-18-39-28-40(61-4)30-52(66-39)23-20-34(3)53(70-52)31-45(42(68-53)16-11-9-7-8-10-15-41(56)50(60)63-6)65-46(57)29-38-14-12-13-37(64-38)26-35(54)25-36(55)27-44(32)67-51/h8-11,32-45,47-49,54-56,58-59H,7,12-31H2,1-6H3/b10-8-,11-9+/t32-,33-,34-,35-,36-,37-,38+,39+,40-,41+,42-,43-,44+,45-,47-,48-,49-,51-,52+,53+/m0/s1.
What are the key properties of methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate?
methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate has a molecular weight of 995.25 g/mol, XLogP of 5.61, 9 rotatable bonds, 5 hydrogen bond donors, and 17 hydrogen bond acceptors.
Where does this data come from?
All data for methyl (2R,4Z,7E)-2-hydroxy-9-[(1R,3S,4S,8R,12S,14S,16S,18R,19S,22S,25S,26R,27S,28S,29S,32R,34S,36R,39S)-14,16,27,28-tetrahydroxy-25,34-dimethoxy-19,29,39-trimethyl-6-oxo-2,5,40,41,42,43,44-heptaoxaheptacyclo[34.3.1.11,4.18,12.118,22.122,26.132,36]pentatetracontan-3-yl]nona-4,7-dienoate is sourced from PubChem (CID 70696902), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).